Using the Chick Embryo Model to Examine the Effects of Hypoxia Pre-conditioning of Uveal Melanoma Cells on Tumor Growth and Metastasis

References

• Carvajal RD, Schwartz GK, Tezel T, Marr B, Francis JH, Nathan PD. Metastatic disease from uveal melanoma: treatment options and future prospects. Br J Ophthalmol. 2017;101(1):38–44. doi:10.1136/bjophthalmol-2016-309034
   PubMed Web of Science ®Google Scholar
• Eleuteri A, Taktak AFG, Coupland SE, Heimann H, Kalirai H, Damato B. Prognostication of metastatic death in uveal melanoma patients: a Markov multi-state model. Comput Biol Med. 2018;102:151–156. doi:10.1016/j.compbiomed.2018.09.024
   PubMed Web of Science ®Google Scholar
• Onken MD, Worley LA, Ehlers JP, Harbour JW. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res. 2004;64(20):7205–7209. doi:10.1158/0008-5472.CAN-04-1750
   PubMed Web of Science ®Google Scholar
• Smit KN, Jager MJ, de Klein A, Kiliҫ E. Uveal melanoma: towards a molecular understanding. Prog Retin Eye Res. 2020;75:100800. doi:10.1016/j.preteyeres.2019.100800
   PubMed Web of Science ®Google Scholar
• Chang SH, Worley LA, Onken MD, Harbour JW. Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis. Melanoma Res. 2008;18(3):191–200. doi:10.1097/CMR.0b013e3283005270
   PubMed Web of Science ®Google Scholar
• Eales KL, Hollinshead KE, Tennant DA. Hypoxia and metabolic adaptation of cancer cells. Oncogenesis. 2016;5(1):e190. doi:10.1038/oncsis.2015.50
   PubMed Web of Science ®Google Scholar
• Schito L, Semenza GL. Hypoxia-inducible factors: master regulators of cancer progression. Trends Cancer. 2016;2(12):758–770. doi:10.1016/j.trecan.2016.10.016
   PubMed Web of Science ®Google Scholar
• Almendros I, Gozal D. Intermittent hypoxia and cancer: undesirable bed partners? Respir Physiol Neurobiol. 2018;256:79–86. doi:10.1016/j.resp.2017.08.008
   PubMed Web of Science ®Google Scholar
• Martinive P, Defresne F, Bouzin C, Saliez J, Lair F, Grégoire V, Michiels C, Dessy C, Feron O. Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies. Cancer Res. 2006;66(24):11736–11744. doi:10.1158/0008-5472.CAN-06-2056
   PubMed Web of Science ®Google Scholar
• Saxena K, Jolly MK. Acute vs. chronic vs. cyclic hypoxia: their differential dynamics, molecular mechanisms, and effects on tumor progression. Biomolecules. 2019;9(8):339. doi:10.3390/biom9080339
   PubMed Web of Science ®Google Scholar
• Herrmann A, Rice M, Lévy R, Pizer BL, Losty PD, Moss D, Sée V. Cellular memory of hypoxia elicits neuroblastoma metastasis and enables invasion by non-aggressive neighbouring cells. Oncogenesis. 2015;4(2):e138. doi:10.1038/oncsis.2014.52
   PubMed Web of Science ®Google Scholar
• Folberg R, Hendrix MJ, Maniotis AJ. Vasculogenic mimicry and tumor angiogenesis. Am J Pathol. 2000;156(2):361–381. doi:10.1016/S0002-9440(10)64739-6
   PubMed Web of Science ®Google Scholar
• Robertson AG, Shih J, Yau C, Gibb EA, Oba J, Mungall KL, Hess JM, Uzunangelov V, Walter V, Danilova L, et al. Integrative analysis identifies four molecular and clinical subsets in uveal melanoma. Cancer Cell. 2017;32(2):204.e15–220.e15. doi:10.1016/j.ccell.2017.07.003
   Web of Science ®Google Scholar
• Ribatti D. Chicken chorioallantoic membrane angiogenesis model. Methods Mol Biol. 2012; 843:47–57. doi:10.1007/978-1-61779-523-7_5
   PubMedGoogle Scholar
• Kain KH, Miller JW, Jones-Paris CR, Thomason RT, Lewis JD, Bader DM, Barnett JV, Zijlstra A. The chick embryo as an expanding experimental model for cancer and cardiovascular research. Dev Dyn. 2014;243(2):216–228. doi:10.1002/dvdy.24093
   PubMed Web of Science ®Google Scholar
• Deryugina EI, Quigley JP. Chick embryo chorioallantoic membrane model systems to study and visualize human tumor cell metastasis. Histochem Cell Biol. 2008;130(6):1119–1130. doi:10.1007/s00418-008-0536-2
   PubMed Web of Science ®Google Scholar
• Kalirai H, Shahidipour H, Coupland SE, Luyten G. Use of the chick embryo model in uveal melanoma. Ocul Oncol Pathol. 2015;1(3):133–140. doi:10.1159/000370151
   PubMedGoogle Scholar
• Luyten GP, Naus NC, Mooy CM, Hagemeijer A, Kan-Mitchell J, Van Drunen E, Vuzevski V, De Jong PT, Luider TM. Establishment and characterization of primary and metastatic uveal melanoma cell lines. Int J Cancer. 1996;66(3):380–387. doi:10.1002/(SICI)1097-0215(19960503)66:3<380::AID-IJC19>3.0.CO;2-F
   PubMed Web of Science ®Google Scholar
• Jager MJ, Magner JA, Ksander BR, Dubovy SR. Uveal melanoma cell lines: where do they come from? (An American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc. 2016;114:T5.
   PubMedGoogle Scholar
• Amirouchene-Angelozzi N, Nemati F, Gentien D, Nicolas A, Dumont A, Carita G, Camonis J, Desjardins L, Cassoux N, Piperno-Neumann S, et al. Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target. Mol Oncol. 2014;8(8):1508–1520. doi:10.1016/j.molonc.2014.06.004
   PubMed Web of Science ®Google Scholar
• Carnero A, Lleonart M. The hypoxic microenvironment: a determinant of cancer stem cell evolution. Bioessays. 2016;38 Suppl 1(Suppl 1):S65–S74. doi:10.1002/bies.201670911
   PubMed Web of Science ®Google Scholar
• Chu PY, Koh AP, Antony J, Huang RY. Applications of the chick chorioallantoic membrane as an alternative model for cancer studies. Cells Tissues Organs. 2022; 211(2):222–237. doi:10.1159/000513039
   PubMed Web of Science ®Google Scholar
• Campillo N, Falcones B, Otero J, Colina R, Gozal D, Navajas D, Farré R, Almendros I. Differential oxygenation in tumor microenvironment modulates macrophage and cancer cell crosstalk: novel experimental setting and proof of concept. Front Oncol. 2019;9:43.
   PubMed Web of Science ®Google Scholar
• Muz B, de la Puente P, Azab F, Azab AK. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia. 2015;3:83–92. doi:10.2147/HP.S93413
   PubMed Web of Science ®Google Scholar
• Semenza GL. HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol. 2001;13(2):167–171. doi:10.1016/s0955-0674(00)00194-0
   PubMed Web of Science ®Google Scholar
• Jha J, Singh MK, Singh L, Pushker N, Lomi N, Meel R, Chosdol K, Sen S, Bakhshi S, Kashyap S. Association of TYRP1 with hypoxia and its correlation with patient outcome in uveal melanoma. Clin Transl Oncol. 2021;23(9):1874–1884. doi:10.1007/s12094-021-02597-7
   PubMed Web of Science ®Google Scholar
• Mouriaux F, Sanschagrin F, Diorio C, Landreville S, Comoz F, Petit E, Bernaudin M, Rousseau AP, Bergeron D, Morcos M. Increased HIF-1α expression correlates with cell proliferation and vascular markers CD31 and VEGF-A in uveal melanoma. Invest Ophthalmol Vis Sci. 2014;55(3):1277–1283. doi:10.1167/iovs.13-13345
   PubMed Web of Science ®Google Scholar
• Brożyna AA, Jóźwicki W, Roszkowski K, Filipiak J, Slominski AT. Melanin content in melanoma metastases affects the outcome of radiotherapy. Oncotarget. 2016;7(14):17844–17853. doi:10.18632/oncotarget.7528
   PubMedGoogle Scholar
• Asnaghi L, Lin MH, Lim KS, Lim KJ, Tripathy A, Wendeborn M, Merbs SL, Handa JT, Sodhi A, Bar EE, Eberhart CG. Hypoxia promotes uveal melanoma invasion through enhanced Notch and MAPK activation. PLoS One. 2014;9(8):e105372. doi:10.1371/journal.pone.0105372
   PubMed Web of Science ®Google Scholar
• Hu K, Babapoor-Farrokhran S, Rodrigues M, Deshpande M, Puchner B, Kashiwabuchi F, Hassan SJ, Asnaghi L, Handa JT, Merbs S, et al. Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma. Oncotarget. 2016;7(7):7816–7828. doi:10.18632/oncotarget.6868
   PubMedGoogle Scholar
• el Filali M, Missotten GS, Maat W, Ly LV, Luyten GP, van der Velden PA, Jager MJ. Regulation of VEGF-A in uveal melanoma. Invest Ophthalmol Vis Sci. 2010;51(5):2329–2337. doi:10.1167/iovs.09-4739
   PubMed Web of Science ®Google Scholar
• Kaluz S, Zhang Q, Kuranaga Y, Yang H, Osuka S, Bhattacharya D, Devi NS, Mun J, Wang W, Zhang R, et al. Targeting HIF-activated collagen prolyl 4-hydroxylase expression disrupts collagen deposition and blocks primary and metastatic uveal melanoma growth. Oncogene. 2021;40(33):5182–5191. doi:10.1038/s41388-021-01919-x
   PubMed Web of Science ®Google Scholar
• Voropaev H, Gimmelshein Vatkin M, Shneor D, Luski S, Honigman A, Frenkel S. Infectious knockdown of CREB and HIF-1 for the treatment of metastatic uveal melanoma. Cancers. 2019;11(8):1056. doi:10.3390/cancers11081056
   PubMed Web of Science ®Google Scholar
• Figueiredo CR, Kalirai H, Sacco JJ, Azevedo RA, Duckworth A, Slupsky JR, Coulson JM, Coupland SE. Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development. J Pathol. 2020;250(4):420–439. doi:10.1002/path.5384
   PubMed Web of Science ®Google Scholar
• Krishna Y, Acha-Sagredo A, Sabat-Pośpiech D, Kipling N, Clarke K, Figueiredo CR, Kalirai H, Coupland SE. Transcriptome profiling reveals new insights into the immune microenvironment and upregulation of novel biomarkers in metastatic uveal melanoma. Cancers. 2020;12(10):2832. doi:10.3390/cancers12102832
   PubMed Web of Science ®Google Scholar
• Krishna Y, McCarthy C, Kalirai H, Coupland SE. Inflammatory cell infiltrates in advanced metastatic uveal melanoma. Hum Pathol. 2017;66:159–166. doi:10.1016/j.humpath.2017.06.005
   PubMed Web of Science ®Google Scholar
• Bronkhorst IH, Jehs TM, Dijkgraaf EM, Luyten GP, van der Velden PA, van der Burg SH, Jager MJ. Effect of hypoxic stress on migration and characteristics of monocytes in uveal melanoma. JAMA Ophthalmol. 2014 May;132(5):614–621. doi:10.1001/jamaophthalmol.2014.43
   PubMed Web of Science ®Google Scholar